MobileODT Selected as UCSF 2021 Health Awards Finalist

On October 10, 2021 MobileODT reported that we are Finalist in the Hospital Diagnostics category for a UCSF 2021 Health Award (Press release, MobileODT, OCT 10, 2021, https://www.mobileodt.com/various/mobileodt-selected-as-ucsf-2021-health-awards-finalist/ [SID1234591048]). The UCSF Health Awards honor outstanding health technologies and innovations dramatically transforming healthcare.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

MobileODT was selected out of thousands of companies, through rigorous judgment rounds, performed by over 300 judges from all over the world. We are extremely honored by this selection, which is a testament to the impact that our technology is making on women’s health.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!